Glaxo strikes marketing deal with Roche

GlaxoSmithKline has signed a deal to co-market Roche's osteoporosis treatment.

Glaxo strikes marketing deal with Roche

GlaxoSmithKline has signed a deal to co-market Roche's osteoporosis treatment.

The two firms are to jointly develop and promote the drug, ibandronate, in all countries except Japan and will share future profits.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €120 €60

Best value

Monthly €10€5 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited